Omeros Submits Narsoplimab MAA to EMA for TA-TMA Treatment
Omeros Corporation announced the recent submission of a Marketing Authorization Application to the European Medicines Agency for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Health...